Aerobid license agreement
Executive Summary
Forest Labs announced it has entered into an agreement with Key for the rights to Aerobid, and anti-asthmatic metered-dose inhaler product. Key licensed the $2.4 mil.-per-year product from patent holder Syntex, which markets the drug in spray form under the brandname Nasalide.